Advanced Medical Isotope (OTCMKTS:RDGL) & Investcorp Credit Management BDC (NASDAQ:ICMB) Critical Review

Investcorp Credit Management BDC (NASDAQ:ICMB) and Advanced Medical Isotope (OTCMKTS:RDGL) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, risk, earnings and valuation.

Profitability

This table compares Investcorp Credit Management BDC and Advanced Medical Isotope’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Investcorp Credit Management BDC	-0.30%	3.33%	1.19%
Advanced Medical Isotope	-6,144.90%	N/A	-113.56%

Institutional & Insider Ownership

7.8% of Investcorp Credit Management BDC shares are owned by institutional investors. 1.3% of Investcorp Credit Management BDC shares are owned by insiders. Comparatively, 18.5% of Advanced Medical Isotope shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Investcorp Credit Management BDC has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Advanced Medical Isotope has a beta of -0.39, suggesting that its stock price is 139% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Investcorp Credit Management BDC and Advanced Medical Isotope, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Investcorp Credit Management BDC	1	0	0	0	1.00
Advanced Medical Isotope	0	0	0	0	0.00

Earnings and Valuation

This table compares Investcorp Credit Management BDC and Advanced Medical Isotope”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Investcorp Credit Management BDC	$23.88 million	1.71	-$144,200.00	($0.01)	-283.00
Advanced Medical Isotope	$30,000.00	1,055.99	-$2.91 million	N/A	N/A

Investcorp Credit Management BDC has higher revenue and earnings than Advanced Medical Isotope.

Summary

Investcorp Credit Management BDC beats Advanced Medical Isotope on 8 of the 10 factors compared between the two stocks.

About Investcorp Credit Management BDC

Investcorp Credit Management BDC, Inc. is a business development company specializing in loan, mezzanine, middle market, growth capital, acquisitions, market/product expansion, organic growth, refinancings and recapitalization investments. It also selectively invests in mezzanine loans/structured equity and in the equity of portfolio companies through warrants and other instruments, in most cases taking such upside participation interests as part of a broader investment relationship. The fund typically invests in United States and Europe. Within United States, the fund seeks to invest in Midatlantic, Midwest, Northeast, Southeast, and West Coast regions. The fund primarily invests in cable and satellites; consumer services; healthcare equipment and services; industrials; information technology; telecommunication services; and utilities sectors. The fund seeks to invest between $5 million to $25 million in companies that have annual revenues of at least $50 million with EBITDA at least $15 million.

About Advanced Medical Isotope

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.